Showing results (311-320 of 419) with videos related to
Sort By:
Pageof 42
Annals of the Rheumatic Diseases|March 12, 2017
Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2016 update of the EULAR recommendations for the management of rheumatoid arthritisJackie L Nam, Kaoru Takase-Minegishi, Sofia Ramiro, et al.Rheumatology and Therapy|December 31, 2021
Safety Profile of Upadacitinib up to 3 Years in Psoriatic Arthritis: An Integrated Analysis of Two Pivotal Phase 3 TrialsGerd R Burmester, Kevin Winthrop, Ricardo Blanco, et al.Annals of the Rheumatic Diseases|February 9, 2020
Efficacy of pharmacological treatment in rheumatoid arthritis: a systematic literature research informing the 2019 update of the EULAR recommendations for management of rheumatoid arthritisAndreas Kerschbaumer, Alexandre Sepriano, Josef S Smolen, et al.BMC Musculoskeletal Disorders|August 1, 2015
Prognostic factors for abatacept retention in patients who received at least one prior biologic agent: an interim analysis from the observational, prospective ACTION studyHubert G Nüßlein, Rieke Alten, Mauro Galeazzi, et al.Annals of the Rheumatic Diseases|December 14, 2012
Efficacy and safety of mavrilimumab in subjects with rheumatoid arthritisGerd R Burmester, Michael E Weinblatt, Iain B McInnes, et al.RMD Open|January 3, 2023
Non-pharmacological interventions to promote work participation in people with rheumatic and musculoskeletal diseases: a systematic review and meta-analysis from the EULAR taskforce on healthy and sustainable work participationMaarten H P Butink, Casper Webers, Suzanne M M Verstappen, et al.Clinical and Experimental Rheumatology|July 8, 2016
Effects of treatment with etanercept versus methotrexate on sleep quality, fatigue and selected immune parameters in patients with active rheumatoid arthritisJacqueline Detert, René Dziurla, Paula Hoff, et al.The Lancet. Rheumatology|January 22, 2024
Methotrexate plus ustekinumab versus ustekinumab monotherapy in patients with active psoriatic arthritis (MUST): a randomised, multicentre, placebo-controlled, phase 3b, non-inferiority trialMichaela Koehm, Tanja Rossmanith, Ann C Foldenauer, et al.Biomaterials|February 7, 2002
The characterisation of human respiratory epithelial cells cultured on resorbable scaffolds: first steps towards a tissue engineered tracheal replacementBrian W Ziegelaar, Joachim Aigner, Rainer Staudenmaier, et al.Clinical Immunology (Orlando, Fla.)|August 30, 2016
Genomic stratification by expression of HLA-DRB4 alleles identifies differential innate and adaptive immune transcriptional patterns - A strategy to detect predictors of methotrexate response in early rheumatoid arthritisBruno Stuhlmüller, Karsten Mans, Neeraj Tandon, et al.Pageof 42